Results 91 to 100 of about 4,425,847 (185)

Ecological Adaptation Mechanisms Underlying Successful Plant Reproduction

Advanced Science, Volume 13, Issue 38, 9 July 2026.
During floral induction, various environmental and endogenous signals converge to regulate the florigen protein, which is transported from leaves to the SAM to initiate flowering. Within the SAM, a complex network of receptor kinases and small peptides orchestrates floral development with high spatiotemporal precision.
Hang Zhao, Shenghui Huo, Yue Xing, Shuxin Zhang, Guilin Li, Yihui Liu, Chongyang Jin, Fuguang Li, Xiaoyang Ge   +8 more
wiley   +1 more source

Cytokine-induced killer cells: new insights for therapy of hematologic malignancies

Stem Cell Research & Therapy
Background Cytokine-induced killer (CIK) cells are a novel subgroup of immune effectors, classified as one of the modified T cell-mediated arms for immunotherapy.
Faezeh Ghanbari Sevari, Amir Mehdizadeh, Khadijeh Abbasi, Seyyed Sina Hejazian, Mortaza Raeisi   +4 more
doaj   +1 more source

Electroencephalogram‐Driven Recognition of Parkinson's Disease Through a Mycelium‐Inspired Memristive Reservoir Computing Circuit

Advanced Intelligent Systems, Volume 8, Issue 7, July 2026.
This work presents a bio‐inspired computing framework for Parkinson's disease analog recognition using electroencephalogram signals. Temporally encoded EEG features stimulate a mycelium‐inspired memristive reservoir, where disease‐related patterns emerge through physical spatiotemporal dynamics.
Ioannis K. Chatzipaschalis, Ioannis Tompris, Pantelis Fraidakis, Iosif‐Angelos Fyrigos, Antonio Rubio, Georgios Ch. Sirakoulis   +5 more
wiley   +1 more source

Co-culture of dendritic cells and cytokine-induced killer cells effectively suppresses liver cancer stem cell growth by inhibiting pathways in the immune system

BMC Cancer, 2018
Background Application of dendritic cells (DC) for cancer immunotherapy involves tumor-associated immunogenic antigens for effective therapeutic strategies.
Tao Yang, Wenjun Zhang, Li Wang, Chunyan Xiao, Li Wang, Yi Gong, Dehong Huang, Bingling Guo, Qiying Li, Ying Xiang, Yingyu Nan   +10 more
doaj   +1 more source

The maturity of dendritic cells (A,C) and CIK cells (B, D) was determined by measuring the percentage of cells expressing DR and CD11c, CD83 (DC markers), and CD3/CD8, CD3/CD56 (CIK cell markers) in blood samples collected from treated colorectal cancer patients.

, 2014
The maturity of dendritic cells (A,C) and CIK cells (B, D) was determined by measuring the percentage of cells expressing DR and CD11c, CD83 (DC markers), and CD3/CD8, CD3/CD56 (CIK cell markers) in blood samples collected from treated colorectal cancer ...
Ronghua Zhao (546826), Xihe Xie (546821), Daiqing Gao (546819), Changyou Li (546820), Peng Zhao (128233), Aris T. Alexandrou (546825), Jennifer Jones (92320), Xiaofang Wei (546822), Hsin-Chen Liu (546824), Weihong Sun (546823), Jian Jian Li (243325)   +10 more
core   +1 more source

Human CIK Cells Loaded with Au Nanorods as a Theranostic Platform for Targeted Photoacoustic Imaging and Enhanced Immunotherapy and Photothermal Therapy [PDF]

, 2016
How to realize targeted photoacoustic imaging, enhanced immunotherapy, and photothermal therapy of gastric cancer has become a great challenge. Herein, we reported for the first time that human cytokine-induced killer cells (CIK) loaded with gold ...
Yao Yang, Cheng, S, Caixia Yue, Jin, W, Shangli Cheng, Qian, Q, Zhi, X, Qirong Qian, Yang, Y, Jingjing Zhang, Daxiang Cui, Cui, D, Shan Fang, Fangfang Xia, Chunlei Zhang, Zhang, C, Sun, R, Yue, C, Weilin Jin, Rongjin Sun, Xia, F, Fang, S, Xiao Zhi, Yuming Yang, Zhang, J, Yue, Caixia, Jin, Weilin, Zhang, Jingjing, Yang, Yuming, Yang, Yao, Cui, Daxiang, Zhang, Chunlei   +31 more
core   +2 more sources

Mitigating the Effects of CEO Overconfidence: A Group Information Processing Perspective

Corporate Governance: An International Review, Volume 34, Issue 4, Page 897-921, July 2026.
ABSTRACT Research Question/Issue This study explores the moderating effects of board network centrality on the relationship between CEO overconfidence and acquisition intensity. Research Findings/Insights Using a panel of S&P 1500 firms from 2002 to 2018, we find that CEO overconfidence is positively associated with acquisition intensity.
Jun Xu, Lin Li, Haibo Liu, Wanrong Hou, Qi Zhu   +4 more
wiley   +1 more source

Ex-vivo and in vivo cytotoxic assay for human CIK cells.

, 2023
A. Ex-vivo cytotoxicity assay of CIK cells against human cancer cell lines in terms of the percentage of cells expressing Annexin 5 and AAD7. In the case of the K562 cell line, the effector:target ratio (E:T) ranged from 1:10 to 5:1 (N = 3).
Ching-Hsun Hu (14328999), Jian-He Fang (636526), Chun-Yen Lin (298233), Chan-Keng Yang (9548675), Tse-Ching Chen (146382), Yung-Chang Lin (636527), Chien-Hao Huang (298239)   +6 more
core   +1 more source

Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL [PDF]

, 2017
Invariant natural killer T (iNKT)/natural killer (NK)/cytokine-induced killer (CIK) cells are important for immune surveillance. (I) Novel combinations of antibody 6B11 (targeting the V alpha 24-J alpha 18-invariant T-cell receptor) with CD4/CD8/CD1d/V ...
Salih, Helmut, Fatemeh Doraneh-Gard, Wishnu Sutanto, Günther, Thomas, Sutanto, Wishnu, Friedhelm Schuster, Schmetzer, Helga, Florian Babor, Amberger, Daniel C., Doraneh-Gard, Fatemeh, Borkhardt, Arndt, Corinna L. Boeck, Schmohl, Jörg, Helga Schmetzer, Arndt Borkhardt, Daniel C. Amberger, Joerg Schmohl, Böck, Corinna L., Helmut Salih, Thomas Guenther, Schuster, Friedhelm, Babor, Florian   +21 more
core   +1 more source

SMAC mimetic BV6 enables sensitization of resistant tumor cells but also affects cytokine-induced killer (CIK) cells: a potential challenge for combination therapy [PDF]

, 2014
Allogeneic hematopoietic stem cell transplantation (HSCT) is an established treatment option for high-risk hematological malignancies, and may also be offered to patients with solid malignancies refractory to conventional therapies.
Verena Pfirrmann, Sabine Huenecke, Andre M. Willasch, Peter Bader, Simone eFulda, Verena ePfirrmann, Eva Rettinger, Thomas Klingebiel, Eva eRettinger, Sabine eHuenecke, Hermann eKreyenberg, Selim Kuçi, Andreas Glatthaar, Behnaz Ahangarian Abhari, Andre M Willasch, Andreas eGlatthaar, Simone Fulda, Sarah eOelsner, Thomas eKlingebiel, Hermann Kreyenberg, Peter eBader, Selim eKuci, Behnaz eAhangarian Abhari, Sarah Oelsner   +23 more
core   +1 more source